Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? Yes
Write-up: Myocardial infarction; This is a spontaneous report received from a contactable consumer downloaded from the Agency Regulatory Authority-WEB. The regulatory authority report number is CZ-CZSUKL-21003913. An 80-year-old (also reported as "76-year-old") male patient received the second dose (dose 2) of BNT162B2 (COMIRNATY), via intramuscular (IM) on 01Apr2021 (Lot Number: ET7205) as single dose for covid-19 immunisation. Medical history included ongoing Type II diabetes mellitus, ongoing failure kidney on dialysis, ongoing cardiac arrhythmia (NOS). There were no concomitant medications. The patient received the first dose of BNT162B2 (COMIRNATY), via intramuscular on 04Mar2021 (lot number unknown) as single dose for covid-19 immunisation. The patient experienced myocardial infarction on 01Apr2021. The event reported as serious and caused death outcome, hospitalization, medically significant, life threatening. The patient was hospitalized for myocardial infarction from 01Apr2021. Myocardial infarction 45 minutes after the administration of the 2nd dose of vaccine. The patient has never had an infarction before. After the repeated resuscitation and subsequent operation, the patient died on 01Apr2021 due to myocardial infarction. An autopsy was not performed. ; Reported Cause(s) of Death: Myocardial infarction
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166